about
Medical treatment for small abdominal aortic aneurysmsMetabolomics with LC-QTOF-MS permits the prediction of disease stage in aortic abdominal aneurysm based on plasma metabolic fingerprintPrevention of abdominal aortic aneurysm by anti-microRNA-712 or anti-microRNA-205 in angiotensin II-infused miceNew Insights Into Aortic Diseases: A Report From the Third International Meeting on Aortic Diseases (IMAD3)The ω-3 polyunsaturated fatty acid, eicosapentaenoic acid, attenuates abdominal aortic aneurysm development via suppression of tissue remodeling.Novel aspects of the pathogenesis of aneurysms of the abdominal aorta in humans.Combination therapy with atorvastatin and amlodipine suppresses angiotensin II-induced aortic aneurysm formation.Pharmacological inhibitor of notch signaling stabilizes the progression of small abdominal aortic aneurysm in a mouse model.Heat shock protein 90 inhibition by 17-DMAG attenuates abdominal aortic aneurysm formation in miceStatin therapy reduces growth of abdominal aortic aneurysms.Toll-Like Receptor 4 Is Essential in the Development of Abdominal Aortic AneurysmTissue- and plasma-specific MicroRNA signatures for atherosclerotic abdominal aortic aneurysmIntravenous administration of mesenchymal stem cells prevents angiotensin II-induced aortic aneurysm formation in apolipoprotein E-deficient mouseStandardization of outcome measures in clinical trials of pharmacological treatment for abdominal aortic aneurysm.Potential role for anti-angiogenic therapy in abdominal aortic aneurysms.Upregulated signaling pathways in ruptured human saccular intracranial aneurysm wall: an emerging regulative role of Toll-like receptor signaling and nuclear factor-κB, hypoxia-inducible factor-1A, and ETS transcription factors.PPAR-γ agonist attenuates inflammation in aortic aneurysm patients.Reversal of Vascular Calcification and Aneurysms in a Rat Model Using Dual Targeted Therapy with EDTA- and PGG-Loaded NanoparticlesInhibition of rho-kinase by fasudil suppresses formation and progression of experimental abdominal aortic aneurysmsClinical practice change requires more than comparative effectiveness evidence: abdominal aortic aneurysm management in the USA.[Treatment of abdominal aortic aneurysms].Baicalein protects against the development of angiotensin II-induced abdominal aortic aneurysms by blocking JNK and p38 MAPK signaling.Endothelium as a Potential Target for Treatment of Abdominal Aortic Aneurysm.Construction of lncRNA-miRNA-mRNA networks reveals functional lncRNAs in abdominal aortic aneurysm
P2860
Q24200789-3645224A-B3D1-4ACC-8965-5C88714214D5Q28481255-A84E2A90-F57D-41F1-A9BB-8E1BAA47E36FQ28505698-C032C61C-8D07-463D-9773-B26601BBBCE1Q30393291-5F44DBFB-8B0E-4626-AD13-64A5E0C858ADQ33567788-93B7A4D7-F847-4989-8F28-7EB70E9876AAQ34682737-C1DEEDD1-9512-42A5-B8A1-4B6C9C4D3F56Q34965343-5D5E1DE9-7B2D-427B-903E-6F79E2CCA373Q35114888-26DFE818-553D-4B88-896D-DDF92230C71EQ35437393-417A30CE-99A5-4F88-8CB5-F4A0F3896F93Q35560673-6F948E88-3499-460F-B39B-EFBC068E98BBQ35888077-7E8C563C-AE93-46CA-AA2B-DD976CECB893Q36522609-F1D048FC-B974-4387-A610-308B52E1CCB2Q37053477-43E874AB-7999-4A41-9EC0-E96B3D74E085Q38056757-70B58A1C-3B3C-4810-9304-DE3AE2E0D21CQ38106736-08B9F68F-5331-4C8F-B956-17C98654F8BBQ38337182-4BB42925-C6DB-4C21-8526-9ABE7A491181Q40693751-B6ABD547-3FD7-4FCD-9803-57443EE412EDQ41200985-B4F7C310-3F79-4BAF-AB69-3D98A77F32E7Q41994097-F62E7833-9AEE-4CFC-AE20-EBE95428C9D3Q42628298-72F7052A-1C4A-4570-B1FB-2856C831A20FQ44834560-7D89D02D-B3FD-4131-8147-D956F10AD801Q46528761-B8F6D3FE-4DB5-4EA1-B67A-56FBB2963FAFQ55195438-D2FF39FE-A58C-4B23-81D9-86917F0184E2Q57787034-E20BC9BF-B221-4B5A-8F32-28B6EBF61DC1
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 19 May 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pharmacological treatment of abdominal aortic aneurysm.
@en
Pharmacological treatment of abdominal aortic aneurysm.
@nl
type
label
Pharmacological treatment of abdominal aortic aneurysm.
@en
Pharmacological treatment of abdominal aortic aneurysm.
@nl
prefLabel
Pharmacological treatment of abdominal aortic aneurysm.
@en
Pharmacological treatment of abdominal aortic aneurysm.
@nl
P2860
P356
P1476
Pharmacological treatment of abdominal aortic aneurysm.
@en
P2093
Ryuichi Morishita
Takashi Miyake
P2860
P304
P356
10.1093/CVR/CVP155
P577
2009-05-19T00:00:00Z